Protalix BioTherapeutics, Inc. Other Non-Current Liabilities
Protalix BioTherapeutics, Inc. (PLX) had Other Non-Current Liabilities of $38.00 thousand as of 2021-06-30, per its 10-Q filed 2021-08-16.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2022-03-31
- 2021-06-30: Other Liabilities, Noncurrent $38.00K.
- 2021-03-31: Other Liabilities, Noncurrent $26.00K.
- 2020-12-31: Other Liabilities, Noncurrent $51.00K.
- 2020-09-30: Other Liabilities, Noncurrent $46.00K.
| Period end | Other Liabilities, Noncurrent |
|---|---|
| 2021-06-30 | $38.00K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $26.00K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $51.00K 10-K · filed 2022-03-31 |
| 2020-09-30 | $46.00K 10-Q · filed 2020-10-29 |
| 2020-06-30 | $124.00K 10-Q · filed 2020-08-10 |
| 2020-03-31 | $210.00K 10-Q · filed 2020-06-01 |
| 2019-12-31 | $509.00K 10-K · filed 2021-03-30 |
| 2019-09-30 | $5.37M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $5.35M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $5.29M 10-Q · filed 2019-05-06 |
| 2018-12-31 | $5.29M 10-K · filed 2020-03-12 |
| 2018-09-30 | $6.15M 10-Q · filed 2019-03-18 |
| 2018-06-30 | $5.26M 10-Q · filed 2019-03-18 |
| 2018-03-31 | $5.17M 10-Q · filed 2019-03-18 |
| 2017-12-31 | $5.05M 10-Q · filed 2019-03-18 |
| 2016-12-31 | $4.30M 10-K · filed 2018-03-06 |
| 2012-03-31 | $5.62M 10-Q · filed 2012-05-09 |
| 2011-12-31 | $6.57M 10-Q · filed 2012-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |